<![CDATA[Pharma — Oktober 2023]]>LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns? https://www.proinvestor.com/investornyt/1057064/lly-isrg-or-jnj-which-healthcare-stock-could-generate-the-best-returns

]]>https://dev.proinvestor.com/forum/topic/400879/pharma-oktober-2023RSS for NodeSun, 07 Jun 2026 04:31:45 GMTSun, 01 Oct 2023 04:02:39 GMT60<![CDATA[Reply to Pharma — Oktober 2023 on Tue, 31 Oct 2023 05:03:30 GMT]]>Lundbecks kursmål løftet til 40 kr. af Citigroup https://www.proinvestor.com/investornyt/1071535/lundbecks-kursmal-loftet-til-40-kr-af-citigroup

]]>https://dev.proinvestor.com/forum/post/8037935https://dev.proinvestor.com/forum/post/8037935Tue, 31 Oct 2023 05:03:30 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Fri, 27 Oct 2023 10:35:49 GMT]]>AbbVie Raises 2023 Adj. EPS Guidance; Announces 2024 Dividend Increase https://www.proinvestor.com/investornyt/1070014/abbvie-raises-2023-adj-eps-guidance-announces-2024-dividend-increase

]]>https://dev.proinvestor.com/forum/post/8037933https://dev.proinvestor.com/forum/post/8037933Fri, 27 Oct 2023 10:35:49 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Tue, 24 Oct 2023 03:00:25 GMT]]>Lundbeck får højere kursmål hos SEB https://www.proinvestor.com/investornyt/1067580/lundbeck-far-hojere-kursmal-hos-seb

]]>https://dev.proinvestor.com/forum/post/8037932https://dev.proinvestor.com/forum/post/8037932Tue, 24 Oct 2023 03:00:25 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Mon, 23 Oct 2023 05:17:41 GMT]]>AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment https://www.proinvestor.com/investornyt/1067048/astrazeneca-enhertu-approved-in-eu-for-advanced-non-small-cell-lung-cancer-treatment

]]>https://dev.proinvestor.com/forum/post/8037929https://dev.proinvestor.com/forum/post/8037929Mon, 23 Oct 2023 05:17:41 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Sat, 21 Oct 2023 13:36:42 GMT]]>AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer https://www.proinvestor.com/investornyt/1066848/azn-imfinzi-combination-reduces-risk-of-disease-progression-or-death-by-45-in-endometrial-cancer

]]>https://dev.proinvestor.com/forum/post/8037934https://dev.proinvestor.com/forum/post/8037934Sat, 21 Oct 2023 13:36:42 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Sat, 21 Oct 2023 13:34:00 GMT]]>AstraZeneca: 59% Of Patients Treated With Tagrisso + Chemotherapy Had Complete Brain Tumor Responses https://www.proinvestor.com/investornyt/1066859/astrazeneca-59-of-patients-treated-with-tagrisso-chemotherapy-had-complete-brain-tumor-responses

]]>https://dev.proinvestor.com/forum/post/8037931https://dev.proinvestor.com/forum/post/8037931Sat, 21 Oct 2023 13:34:00 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Sat, 21 Oct 2023 07:58:53 GMT]]>Is Pfizer a Bad News Buy Right Now? https://www.proinvestor.com/investornyt/1066754/is-pfizer-a-bad-news-buy-right-now

]]>https://dev.proinvestor.com/forum/post/8037928https://dev.proinvestor.com/forum/post/8037928Sat, 21 Oct 2023 07:58:53 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Wed, 18 Oct 2023 03:40:51 GMT]]>Morning 🙂

]]>https://dev.proinvestor.com/forum/post/8037927https://dev.proinvestor.com/forum/post/8037927Wed, 18 Oct 2023 03:40:51 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Tue, 17 Oct 2023 03:41:36 GMT]]>godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8037924https://dev.proinvestor.com/forum/post/8037924Tue, 17 Oct 2023 03:41:36 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Mon, 16 Oct 2023 02:05:14 GMT]]>AbbVie : Phase 3 Study Of Skyrizi In Crohn's Disease Meets All Primary And Secondary Endpoints https://www.proinvestor.com/investornyt/1063771/abbvie-phase-3-study-of-skyrizi-in-crohns-disease-meets-all-primary-and-secondary-endpoints

]]>https://dev.proinvestor.com/forum/post/8037925https://dev.proinvestor.com/forum/post/8037925Mon, 16 Oct 2023 02:05:14 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Thu, 12 Oct 2023 03:30:20 GMT]]>Godmorgen 🙂 dejligt med gode nyheder det må så gerne snart kunne ses på aktiekursen for 6 mdr. siden var vi i kurs 112 lad os komme derop igen

]]>https://dev.proinvestor.com/forum/post/8037930https://dev.proinvestor.com/forum/post/8037930Thu, 12 Oct 2023 03:30:20 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Wed, 11 Oct 2023 13:22:24 GMT]]>ALK-Abelló med positive resultater fra studier med behandling af træpollenallergi hos børn https://www.proinvestor.com/investornyt/1062086/alk-abello-med-positive-resultater-fra-studier-med-behandling-af-traepollenallergi-hos-born

]]>https://dev.proinvestor.com/forum/post/8037922https://dev.proinvestor.com/forum/post/8037922Wed, 11 Oct 2023 13:22:24 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Mon, 09 Oct 2023 12:44:00 GMT]]>Lundbeck får løftet kursmålet hos Deutsche Bank https://www.proinvestor.com/investornyt/1061034/lundbeck-far-loftet-kursmalet-hos-deutsche-bank

]]>https://dev.proinvestor.com/forum/post/8037919https://dev.proinvestor.com/forum/post/8037919Mon, 09 Oct 2023 12:44:00 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Sun, 08 Oct 2023 07:01:11 GMT]]>Dagens aktie er AbbVie Inc.

AbbVie er en amerikansk børsnoteret biofarmaceutisk virksomhed der opstod som spin-off af Abbott Laboratories
62+ mio. mennesker behandles årlig med produkter fra AbbVie på tværs af 60+ sygdomme.
Primære områder er Immunologi - Onkologi - Virologi - Neurologi - Æstetik
https://www.proinvestor.com/boards/116020

]]>https://dev.proinvestor.com/forum/post/8037926https://dev.proinvestor.com/forum/post/8037926Sun, 08 Oct 2023 07:01:11 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Fri, 06 Oct 2023 05:32:10 GMT]]>Økonomer: Uden medicinsektoren er industriproduktionen i nedgang https://www.proinvestor.com/investornyt/1059995/okonomer-uden-medicinsektoren-er-industriproduktionen-i-nedgang

]]>https://dev.proinvestor.com/forum/post/8037917https://dev.proinvestor.com/forum/post/8037917Fri, 06 Oct 2023 05:32:10 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Wed, 04 Oct 2023 05:37:40 GMT]]>Alk-Abelló spurter frem i rødt aktiemarked efter varm anbefaling https://www.proinvestor.com/investornyt/1058385/alk-abello-spurter-frem-i-rodt-aktiemarked-efter-varm-anbefaling

]]>https://dev.proinvestor.com/forum/post/8037923https://dev.proinvestor.com/forum/post/8037923Wed, 04 Oct 2023 05:37:40 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Wed, 04 Oct 2023 03:01:06 GMT]]>ALK får løftet anbefaling og kursmål af norsk storbank https://www.proinvestor.com/investornyt/1058352/alk-far-loftet-anbefaling-og-kursmal-af-norsk-storbank

]]>https://dev.proinvestor.com/forum/post/8037916https://dev.proinvestor.com/forum/post/8037916Wed, 04 Oct 2023 03:01:06 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Tue, 03 Oct 2023 11:15:55 GMT]]>Amerikansk biotekaktie får jackpot: Lilly lægger 10 mia. kr. på bordet Amerikansk biotekaktie får jackpot: Lilly lægger 10 mia. kr. på bordet

]]>https://dev.proinvestor.com/forum/post/8037918https://dev.proinvestor.com/forum/post/8037918Tue, 03 Oct 2023 11:15:55 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Tue, 03 Oct 2023 08:43:51 GMT]]>Dagens aktie er H. Lundbeck A/S

H. Lundbeck A/S er et dansk medicinalfirma, som beskæftiger sig med forskning og udvikling, produktion, markedsføring og salg af lægemidler til behandling indenfor hjernesygdomme som depression, skizofreni, parkinsons sygdom, alzheimers sygdom, PTSD og migræne.
Fokuserer på neurologi og psykiatri.
https://www.proinvestor.com/boards/115876/

]]>https://dev.proinvestor.com/forum/post/8037920https://dev.proinvestor.com/forum/post/8037920Tue, 03 Oct 2023 08:43:51 GMT<![CDATA[Reply to Pharma — Oktober 2023 on Mon, 02 Oct 2023 04:28:12 GMT]]>Novartis Announces Positive Results From Phase III Study Of Iptacopan In IgA Nephropathy https://www.proinvestor.com/investornyt/1057193/novartis-announces-positive-results-from-phase-iii-study-of-iptacopan-in-iga-nephropathy

]]>https://dev.proinvestor.com/forum/post/8037921https://dev.proinvestor.com/forum/post/8037921Mon, 02 Oct 2023 04:28:12 GMT